Congenital adrenal hyperplasia

Endocrinology and Metabolism Clinics of North America

Volumn 26, Issue 4, 1997, Pages 853-891

  Pang, S ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOTROPIN; DEXAMETHASONE; STEROID 21 MONOOXYGENASE;

CONGENITAL ADRENAL HYPERPLASIA; CORTICOSTEROID THERAPY; CORTICOTROPIN RELEASE; CUSHINGOID SYNDROME; GENE MUTATION; GENETIC VARIABILITY; GENOTYPE; HUMAN; NEWBORN SCREENING; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; VIRILIZATION;

EID: 0030663094     PISSN: 08898529     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0889-8529(05)70285-1     Document Type: Article

References (119)

1. Allen DB, Hoffman GL, Mahy SL, et al: Improved precision of newborn screening for 21-hydroxylase deficiency congenital adrenal hyperplasia (21-OH CAH) using weight-adjusted criteria for 17-hydroxyprogesterone (17-OHP) levels. In Programs and Abstracts of the Pediatric Research, APS-SPR Annual Meeting, 1995, 37:P84A
2. R. Azziz D. Dewailly D. Owerbach Clinical review 56: Nonclassic adrenal hyperplasia. Current concepts J Clin Endocrinol Metab 78 1994 810
3. R. Azziz G. Wells H.A. Zacur Abnormalities of 21-hydroxylase gene ratio and adrenal steroidogenesis in hyperandrogenic women with an exaggerated 17-hydroxyprogesterone response to acute adrenal stimulation J Clin Endocrinol Metab 73 1991 1327
4. A.M. Bongiovanni G. Kellenbenz The adrenogenital syndrome with deficiency of 3β-hydroxysteroid dehydrogenase J Clin Invest 41 1962 2086
5. H.S. Bose T. Sugawara J.F. Strauss The pathophysiology and genetics of congenital lipoid adrenal hyperplasia N Engl J Med 335 1996 1870
6. J. Bristow S.E. Gitelman M.K. Tee Abundant adrenal-specific transcription of the human P450c21A “pseudogene.” J Biol Chem 268 1993 12919
7. J.F. Cara T. Moshang A.M. Bongiovanni Elevated 17-hydroxyprogesterone and testosterone in a newborn with 3-beta-hydroxysteroid dehydrogenase deficiency N Engl J Med 313 1985 618
8. E. Carmina R.A. Lobo Ovarian suppression reduces clinical and endocrine expression of late-onset congenital adrenal hyperplasia due to 21-hydroxylase deficiency Fertil Steril 62 1994 738
9. S. Chang B. Chung Difference in transcriptional activity of two homologous CYP21A genes Mol Endocrinol 9 1995 1330
10. Y.T. Chang M.S. Kappy K. Iwamoto Mutations in the type II 3β-hydroxysteroid dehydrogenase gene in a patient with classic salt-wasting 3β-hydroxysteroid dehydrogenase deficiency congenital adrenal hyperplasia Pediatr Res 34 1993 698
11. Y.T. Chang H.E. Kulin L. Garibaldi Hypothalamic-pituitary-gonadal axis function in pubertal male and female siblings with glucocorticoid-treated nonsalt-wasting 3β-hydroxysteroid dehydrogenase deficiency congenital adrenal hyperplasia J Clin Endocrinol Metab 77 1993 1251
12. Y.T. Chang L. Zhang H.S. Alkaddour Absence of molecular defect in the type II 3β-hydroxysteroid dehydrogenase (3β-HSD) gene in premature pubarche children and hirsute female patients with moderately decreased adrenal 3β-HSD activity Pediatr Res 37 1995 820
13. 356→ Trp causes steroid 21-hydroxylase deficiency J Biol Chem 265 1990 3549
14. Committee on Genetics Newborn screening fact sheets Pediatrics 98 1996 473
15. M. David M.G. Forest Prenatal treatment of congenital adrenal hyperplasia resulting from 21-hydroxylase deficiency J Pediatr 105 1984 799
16. D. Dewailly M. Vantyghem-Haudiquet C. Sainsard Clinical and biological phenotypes in late-onset 21-hydroxylase deficiency J Clin Endocrinol Metab 63 1986 418
17. P.K. Donahoe J.J. Schnitzer Evaluation of the infant who has ambiguous genitalia and principles of operative management Semin Pediatr Surg 5 1996 30
18. H.G. Dorr W.G. Sippel Prenatal dexamethasone treatment in pregnancies at risk for congenital adrenal hyperplasia due to 21-hydroxylase deficiency: Effect on midgestational amniotic fluid steroid levels J Clin Endocrinol Metab 76 1993 117
19. D.A. Ehrmann R.L. Rosenfield R.B. Barnes Detection of functional ovarian hyperandrogenism in women with androgen excess N Engl J Med 327 1992 157
20. T. Eldar-Geva A. Hurwitz P. Vecsei Secondary biosynthetic defects in women with late-onset congenital adrenal hyperplasia N Engl J Med 323 1990 855
21. S. Feldman L. Billaud J. Thalabard Fertility in women with late-onset adrenal hyperplasia due to 21-hydroxylase deficiency J Clin Endocrinol Metab 74 1992 635
22. P. Feuillan S. Pang T. Schurmeyer The hypothalamic-pituitary-adrenal axes in partial (late-onset) 21-hydroxylase deficiency J Clin Endocrinol Metab 67 1988 154
23. J. Fiet B. Gueux M. Raux-Demay Increased plasma 21-deoxycorticosterone (21-DB) levels in late-onset adrenal 21-hydroxylase deficiency suggest a mild defect of the mineralocorticoid pathway J Clin Endocrinol Metab 68 1989 542
24. J. Fiet J.M. Villette H. Galons The application of a new highly sensitive radioim munoassay for plasma 21-deoxycortisol to the detection of steroid-21-hydroxylase deficiency Ann Clin Biochem 31 1994 56
25. M.G. Forest Pitfalls in prenatal diagnosis of 21-hydroxylase deficiency by amniotic fluid steroid analysis: A six-year experience in 102 pregnancies at risk Ann NY Acad Sci 458 1985 130
26. M.G. Forest Y. Morel M. David Prenatal treatment of congenital adrenal hyperplasia due to steroid 21-hydroxylase deficiency Front Endocrinol 17 1996 77
27. M. Gibson R. Lackritz I. Schiff Abnormal adrenal responses to adrenocorticotropic hormone in hyperandrogenic women Fertil Steril 33 1980 43
28. A.R. Glass S.G. Jackson R.S. Perlstein Adrenal insufficiency in a man with nonclassical 21-hydroxylase deficiency: Consequences or coincidence? J Endocrinol Invest 17 1994 665
29. W.M. Hague J.W. Honour J. Adams Steroid responses to ACTH in women with polycystic ovaries Clin Endocrinol 30 1989 355
30. L.A. Hawkins F.I. Chasalow S.L. Blethen The role of adrenocorticotropin testing in evaluating girls with premature adrenarche and hirsutism/oligomenorrhea J Clin Endocrinol Metab 74 1992 248
31. A. Helmberg M. Tusie-Luna M. Tabarelli R339H and P453S: CYP21 mutations associated with nonclassic steroid 21-hydroxylase deficiency that are not apparent gene conversions Mol Endocrinol 6 1992 1318
32. Y. Higashi T. Hiromasa A. Tanae Effects of individual mutations in the P-450 (C21) pseudogene on the P-450 (C21) activity and their distribution in the patient genomes of congenital steroid 21-hydroxylase deficiency J Biochem 109 1991 638
33. Y. Higashi A. Tanae H. Inoue Aberrant splicing and missense mutations cause steroid 21-hydroxylase [P-450 (C21)] deficiency in humans: Possible gene conversion products Biochemistry 85 1988 7486
34. Y. Higashi A. Tanae H. Inoue Evidence for frequent gene conversion in the steroid 21-hydroxylase P-450 (C21) gene: Implications for steroid 21-hydroxylase deficiency Am J Hum Genet 42 1988 17
35. N. Katsumata A. Tanae T. Yasunaga A novel missense mutation in the type II 3β-hydroxysteroid dehydrogenase gene in a family with classical salt-wasting congenital adrenal hyperplasia due to 3β-hydroxysteroid dehydrogenase deficiency Hum Mol Genet 4 1995 745
36. G.J. Klingensmith S.C. Garcia H.W. Jones Glucocorticoid treatment of girls with congenital adrenal hyperplasia: Effects on height, sexual maturation, and fertility J Pediatr 90 1977 966
37. B. Kohn L.S. Levine M.S. Pollack Late-onset steroid 21-hydroxylase deficiency: A variant of classical congenital adrenal hyperplasia J Clin Endocrinol Metab 55 1982 817
38. S. Korth-Schutz R. Virdis P. Saenger Serum androgens as a continuing index of adequacy of treatment of congenital adrenal hyperplasia J Clin Endocrinol Metab 46 1978 452
39. A.A. Kowarski Mechanism of salt loss in congenital virilizing adrenal hyperplasia P.A. Lee L.P. Plotnick A.A. Kowarski C.J. Migeon Congenital Adrenal Hyperplasia 1977 University Park Baltimore 113
40. U. Kuhnle D. Chow R. Rapaport The 21-hydroxylase activity in the glomerulosa and fasciculata of the adrenal cortex in congenital adrenal hyperplasia J Clin Endocrinol Metab 52 1981 534
41. F. Kuttenn P. Couillin F. Girard Late-onset adrenal hyperplasia in hirsutism N Engl J Med 313 1985 224
42. F. Labrie J. Simard V. Luu-The Structure, function and tissue-specific gene expression of 3β-hydroxysteroid dehydrogenase/5-ene-4-ene isomerase enzymes in classical and peripheral intracrine steroidogenic tissues J Steroid Biochem Mol Biol 43 1992 805
43. L. Laue D.P. Merke J.V. Jones A preliminary study of flutamide, testolactone, and reduced hydrocortisone dose in the treatment of congenital adrenal hyperplasia J Clin Endocrinol Metab 81 1996 3535
44. L.S. Levine B. Dupont F. Lorenzen Genetic and hormonal characterization of cryptic 21-hydroxylase deficiency J Clin Endocrinol Metab 53 1981 1193
45. L.S. Levine S. Pang Prenatal diagnosis and treatment of congenital adrenal hyperplasia J Pediatr Endocrinol 3 1994 193
46. Levine LS, Pang S: Prenatal diagnosis and treatment of congenital adrenal hyperplasia. In Milunsky A (ed): Genetic Disorders and the Fetus. Baltimore, Hopkins, (in press), 1997
47. L.S. Levine W. Rauh K. Gottesdiener New studies of the 11β-hydroxylase and the 18-hydroxylase enzymes in the hypertensive form of congenital adrenal hyperplasia (CAH) J Clin Endocrinol Metab 50 1980 258
48. L.S. Levine M. Zachmann M.I. New Genetic mapping of the 21-hydroxylase deficiency gene within the HLA linkage group N Engl J Med 299 1978 911
49. R.A. Lobo U. Goebelsmann Evidence for reduced 3β-ol-hydroxysteroid dehydrogenase activity in some hirsute women thought to have polycystic ovary syndrome J Clin Endocrinol Metab 53 1981 394
50. F. Lorenzen S. Pang M.I. New Studies of the C-21 and C-19 steroids and HLA genotyping in siblings and parents of patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency J Clin Endocrinol Metab 50 1980 572
51. Marui S, Torrealba IM, Russell AJ, et al: A novel homozygous nonsense mutation E135X in the type II 3β-hydroxysteroid dehydrogenase gene of a female child with salt-losing congenital adrenal hyperplasia. In Programs of the 10th International Congress of Endocrinology, San Francisco, 1996, p 895
52. J.I. Mason The 3β-hydroxysteroid dehydrogenase gene family of enzymes Trends Endocrinol Metab 4 1993 199
53. B.B. Mendonca W. Bloise I. Arnhold Male pseudohermaphroditism due to nonsalt-losing 3β-hydroxysteroid dehydrogenase deficiency: Gender role change and absence of gynecomastia at puberty J Steroid Biochem 28 1987 669
54. B.B. Mendonca A.J. Russell M. Vasconcelos-Leite Mutation in 3β-hydroxysteroid dehydrogenase type II associated with pseudohermaphroditism in males and premature pubarche or cryptic expression in females J Mol Endocrinol 12 1994 119
55. A.B. Mercado R.C. Wilson K.C. Cheng Prenatal treatment and diagnosis of congenital adrenal hyperplasia owing to steroid 21-hydroxylase deficiency J Clin Endocrinol Metab 80 1995 2014
56. C. Migeon P.A. Danohoue Adrenal disorders M.S. Koppy R.M. Blizzard C.L. Migeon Textbook of Diagnosis and Treatment of Endocrine Disorders in Childhood and Adolescence ed 4 1994 C. Thomas Springfield, IL 717
57. W.L. Miller L.S. Levine Molecular and clinical advances in congenital adrenal hyperplasia J Pediatr 111 1987 1
58. Y. Morel W.L. Miller Clinical and molecular genetics of congenital adrenal hyperplasia due to 21-hydroxylase deficiency H. Harris K. Hirschhorn Advances in Human Genetics 1991 Plenum New York 1
59. Y. Morel M. Murena M.G. Forest Prenatal diagnosis of congenital adrenal hyperplasia due to 21-hydroxylase deficiency Pediatr Res 33 5 suppl 1993 S3
60. E. Mornet J. Boue M. Raux-Demay First-trimester prenatal diagnosis of 21-hydroxylase deficiency by linkage analysis to HLA-DNA probes and by 17-hydroxyprogesterone determination Hum Genet 73 1986 358
61. E. Mornet P. Crété F. Kuttenn Distribution of deletions and seven point mutations on CYP21B genes in three clinical forms of steroid 21-hydroxylase deficiency Am J Hum Genet 48 1991 79
62. Nass R, Heier L, Moshang T, et al: Magnetic resonance imaging in the congenital adrenal hyperplasia population: Increased frequency of white-matter abnormalities and temporal lobe atrophy. J Child Neurol, in press
63. M.I. New J.M. Gertner M.B. Chir Growth and final height in classical and nonclassical 21-hydroxylase deficiency Acta Paediatr Jpn, 30 suppl 1988 79 88
64. M.I. New F. Lorenzen A.J. Lerner Genotyping steroid 21-hydroxylase deficiency: Hormonal reference data J Clin Endocrinol Metab 57 1983 320
65. Newfield RS, Pascoe L, Curnow KM, et al: Prenatal diagnosis and treatment resulting in normal female genitalia in a fetus affected with congenital adrenal hyperplasia owing to 11β-hydroxylase deficiency (homozygous T318M). In Programs and Abstracts of the 10th International Congress of Endocrinology, San Francisco, 1996, 1:2–734
66. D. Owerbach A. Ballard M.B. Draznin Salt-wasting congenital adrenal hyperplasia: Detection and characterization of mutations in the steroid 21-hydroxylase gene, CYP21, using the polymerase chain reaction J Clin Endocrinol Metab 74 1992 553
67. D. Owerbach L. Sherman A. Ballard Pro-453 to Ser mutation in CYP21 is associated with nonclassic steroid 21-hydroxylase deficiency Mol Endocrinol 6 1992 1211
68. S. Pang Congenital adrenal hyperplasia Baillieres Clinic Obstet Gynaecol 11 1997 281 306
69. S. Pang Congenital adrenal hyperplasia C.W. Bardin Current Therapy in Endocrinology and Metabolism ed 5 1995 Mosby–New Book St. Louis 157
70. Pang S: Congenital adrenal hyperplasia. In Serono Symposia: Current Review of Pediatric Endocrinology, Washington, D.C., 1993, p101
71. S. Pang Hirsutism and polycystic ovary syndrome F. Lipschitz Pediatric Endocrinology: A Clinical Guide ed 3 1995 Marcel Dekker New York 235
72. S. Pang A. Clark Congenital adrenal hyperplasia due to 21-hydroxylase deficiency: Newborn screening and its relationship to the diagnosis and treatment of the disorder Screening 2 1993 105
73. S. Pang A.T. Clark L.C. Freeman Maternal side effects of prenatal dexamethasone therapy for fetal congenital adrenal hyperplasia J Clin Endocrinol Metab 75 1992 249
74. S. Pang J. Hotchkiss A.L. Drash Microfilter paper method for 17-hydroxyprogesterone radioimmunoassay: Its application for rapid screening for congenital adrenal hyperplasia J Clin Endocrinol Metab 45 1977 1003
75. S. Pang A.J. Lerner E. Stoner Late-onset adrenal steroid 3β-hydroxysteroid dehydrogenase deficiency I: A cause of hirsutism in pubertal and postpubertal women J Clin Endocrinol Metab 60 1985 428
76. S. Pang L.S. Levine L.L. Cederqvist Amniotic fluid concentrations of Δ5 and Δ4 steroids in fetuses with congenital adrenal hyperplasia due to 21-hydroxylase deficiency and in anencephalic fetuses J Clin Endocrinol Metab 51 1980 223
77. S. Pang L.S. Levine D.M. Chow Serum androgen concentrations in neonates and young infants with congenital adrenal hyperplasia due to 21-hydroxylase deficiency Clin Endocrinol 11 1979 575
78. S. Pang L.S. Levine E. Stoner Nonsalt-losing congenital adrenal hyperplasia due to 3β-hydroxysteroid dehydrogenase deficiency with normal glomerulosa function J Clin Endocrinol Metab 56 1983 808
79. S. Pang M.S. Pollack M. Loo Pitfalls of prenatal diagnosis of 21-hydroxylase deficiency congenital adrenal hyperplasia J Clin Endocrinol Metab 61 1985 81
80. S. Pang M.S. Pollack R.N. Marshall Prenatal treatment of congenital adrenal hyperplasia due to 21-hydroxylase deficiency N Engl J Med 322 1990 111
81. E.L. Potter Pathology of the Fetus and the Newborn 1952 Year Book Chicago 330
82. E. Rhéaume R. Sanchez F. Mébarki Identification and characterization of the G15D mutation found in a male patient with 3β-hydroxysteroid dehydrogenase (3-HSD) deficiency: Alteration of the putative NAD-binding domain of the type II 3β-HSD Biochemistry 34 1995 2893
83. E. Rhéaume R. Sanchez J. Simard Molecular basis of congenital adrenal hyperplasia in two siblings with classical nonsalt-losing 3β-hydroxysteroid dehydrogenase deficiency J Clin Endocrinol Metab 79 1994 1012
84. E. Rhéaume J. Simard Y. Morel Congenital adrenal hyperplasia due to point mutations in the type II 3β-hydroxysteroid dehydrogenase gene Nature Genet 1 1992 239
85. 5-3β-hydroxysteroid dehydrogenase deficiency J Clin Endocrinol Metab 51 1980 345
86. A.J. Russell A.M. Wallace M.G. Forest Mutation in the human gene for 3β-hydroxysteroid dehydrogenase type II leading to male pseudohermaphroditism without salt loss J Mol Endocrinol 12 1994 225
87. H. Sakkal-Alkaddour L. Zhang X. Yang Studies of 3β-hydroxysteroid dehydrogenase genes in infants and children manifesting premature pubarche and increased ACTH stimulation Δ5 steroid levels J Clin Endocrinol Metab 81 1996 3961
88. R. Sanchez F. Mebarki E. Rheume Functional characterization of the novel L108W and P186L mutations detected in the type II 3 beta-hydroxysteroid dehydrogenase gene of a male pseudohermaphrodite with congenital adrenal hyperplasia Hum Mol Genet 3 1994 1639
89. R. Sanchez E. Rhéaume N. Laflamme Detection and functional characterization of the novel missense mutation Y254D in type II 3β-hydroxysteroid dehydrogenase (3β-HSD) gene of a female patient with nonsalt-losing 3β-HSD deficiency J Clin Endocrinol Metab 78 1994 561
90. G. Schneider M. Genel A.M. Bongiovanni Persistent testicular Δ5-isomerase-3β-hydroxysteroid dehydrogenase (Δ5-3β-HSD) deficiency in the Δ5-3β-HSD form of congenital adrenal hyperplasia J Clin Invest 55 1975 681
91. S.F. Siegel D.N. Finegold R. Lanes ACTH stimulation tests and plasma dehydroepiandrosterone sulfate levels in women with hirsutism N Engl J Med 323 1990 849
92. T.M. Siler-Khodr L.L. Morgenstern F.C. Greenwood Hormone synthesis and release from human fetal adenohypophyses in vitro J Clin Endocrinol Metab 39 1974 891
93. J. Simard E. Rhéaume J.F. Leblanc Congenital adrenal hyperplasia caused by a novel homozygous frameshift mutation 273ΔAA in type II 3β-hydroxysteroid dehydrogenase gene (HSD 3β2) in three male patients of Afghan/Pakistani origin Hum Mol Genet 3 1994 327
94. J. Simard E. Rhéaume R. Sanchez Molecular basis of congenital adrenal hyperplasia due to 3β-hydroxysteroid dehydrogenase deficiency Mol Endocrinol 7 1993 716
95. W.G. Sippel H.G. Dorr F. Bidlingmaier Plasma levels of aldosterone, corticosterone, 11-deoxycorticosterone, progesterone, 17-hydroxyprogesterone, cortisol, and cortisone during infancy and childhood Pediatr Res 14 1980 39
96. P.W. Speiser L. Agdere H. Ueshiba Aldosterone synthesis in patients with salt-wasting congenital adrenal hyperplasia (21-hydroxylase deficiency) and complete absence of adrenal 21-hydroxylase (p450c21) N Engl J Med 324 1991 145
97. P.W. Speiser B. DuPont P. Rubinsterin High frequency of nonclassic steroid 21-hydroxylase deficiency Am J Hum Genet 37 1985 650
98. P.W. Speiser J. Dupont D. Zhu Disease expression and molecular genotype in congenital adrenal hyperplasia due to 21-hydroxylase deficiency J Clin Invest 90 1992 584
99. P.W. Speiser N. Laforgia K. Kato First-trimester prenatal treatment and molecular genetic diagnosis of congenital adrenal hyperplasia (21-hydroxylase deficiency) J Clin Endocrinol Metab 70 1990 838
100. P. Spritzer L. Billaud J. Thalabard Cyproterone acetate versus hydrocortisone treatment in late-onset adrenal hyperplasia J Clin Endocrinol Metab 70 1990 642
101. E. Stoner J. DiMartino U. Kuhnle Is salt-wasting in congenital adrenal hyperplasia genetic? Clin Endocrinol 24 1986 9
102. T. Tajima K. Fujieda J. Nakae Molecular analysis of type II 3β-hydroxysteroid dehydrogenase gene in Japanese patients with classical 3β-hydroxysteroid dehydrogenase deficiency Hum Mol Genet 4 1995 969
103. Tardy V, Carel JC, Forest MG, et al: Nonclassical forms of 21-hydroxylase deficiency revisited by molecular biology. In Program and Abstracts of the 10th International Congress of Endocrinology, San Francisco, 1996, p 2-737
104. J.W. Temeck S. Pang C. Nelson Genetic defects of steroidogenesis in premature pubarche J Clin Endocrinol Metab 64 1987 609
105. P.D. Trautman H.F.L. Meyer-Bahlburg J. Postelnek Effects of early prenatal dexamethasone on the cognitive and behavioral development of young children: Results of a pilot study Psychoneuroendocrinology 20 1995 439
106. E.I. Turner M.J. Watson L.A. Perry Investigation of adrenal function in women with oligomenorrhea and hirsutism (clinical PCOS) from the northeast of England using an adrenal stimulation test Clin Endocrinol 36 1992 389
107. M. Tusie-Luna P.W. Speiser M. Dumic A mutation (Pro-30 to Leu) in CYP21 represents a potential nonclassic steroid 21-hydroxylase deficiency allele Mol Endocrinol 5 1991 685
108. M. Tusie-Luna P. Traktman P.C. White Determination of functional effects of mutations in the steroid 21-hydroxylase gene (CYP21) using recombinant vaccinia virus J Biol Chem 265 1990 20916
109. J.J. Van Wyk D.F. Gunther E.M. Ritzen The use of adrenalectomy as a treatment for congenital adrenal hyperplasia J Clin Endocrinol Metab 81 1996 3180
110. A. Wedell Molecular approaches for the diagnosis of 21-hydroxylase deficiency and congenital adrenal hyperplasia Clin Lab Med 16 1996 125
111. A. Wedell H. Luthman Steroid 21-hydroxylase deficiency: Two additional mutations in salt-wasting disease and rapid screening of disease-causing mutations Hum Mol Genet 2 1993 499
112. A. Wedell E.M. Ritzén B. Haglund-Stengler Steroid 21-hydroxylase deficiency: Three additional mutated alleles and establishments of phenotype-genotype relationships of common mutations Proc Natl Acad Sci USA 89 1992 7232
113. A. Wedell A. Thilén E.M. Ritzén Mutational spectrum of the steroid 21-hydroxylase gene in Sweden: Implications for genetic diagnosis and association with disease manifestation J Clin Endocrinol Metab 78 1994 1145
114. P.C. White D. Grossberger B.J. Onufer Two genes encoding steroid 21-hydroxylase are located near the genes encoding the fourth component of complement in man Biochemistry 82 1985 1089
115. E. Youssefnejadian R. David Early diagnosis of congenital adrenal hyperplasia by measurement of 17-hydroxyprogesterone Clin Endocrinol 4 1975 451
116. M. Zachmann M.G. Forest E. De Peretti 3β-hydroxysteroid dehydrogenase deficiency follow-up study in a girl with pubertal bone age Horm Res 11 1979 292
117. M. Zerah E. Rheaume P. Mani No evidence of mutations in the genes for type I and type II 3β-hydroxysteroid dehydrogenase (3β-HSD) in nonclassical 3β-HSD deficiency J Clin Endocrinol Metab 79 1994 1811
118. M. Zerah H. Ueshiba E. Wood Prevalence of nonclassical steroid 21-hydroxylase deficiency based on a morning salivary 17-hydroxyprogesterone screening test: A small sample study J Clin Endocrinol Metab 70 1990 1662
119. L. Zhang H.S. Sakkal-Alkaddour Y.T. Chang A new compound heterozygous frameshift mutation in the type II 3β-hydroxysteroid dehydrogenase (3β-HSD) gene causes salt-wasting 3β-HSD deficiency congenital adrenal hyperplasia J Clin Endocrinol Metab 81 1995 291